NexgenRx Inc. (TSXV:NXG)
0.3600
+0.0200 (5.88%)
Jun 30, 2025, 4:00 PM EDT
NexgenRx Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 16.18 | 15.9 | 13.29 | 12.57 | 11.79 | 10.39 | Upgrade
|
Other Revenue | 0.64 | 0.58 | 0.56 | 0.21 | 0.05 | 0.18 | Upgrade
|
16.82 | 16.48 | 13.85 | 12.78 | 11.84 | 10.57 | Upgrade
| |
Revenue Growth (YoY) | 15.22% | 18.99% | 8.33% | 7.94% | 12.01% | 10.82% | Upgrade
|
Cost of Revenue | 3.48 | 3.35 | 3.03 | 2.6 | 2.03 | 1.38 | Upgrade
|
Gross Profit | 13.34 | 13.12 | 10.82 | 10.18 | 9.81 | 9.2 | Upgrade
|
Selling, General & Admin | 10.8 | 10.64 | 9.62 | 8.43 | 6.18 | 6.49 | Upgrade
|
Operating Expenses | 12.08 | 11.92 | 10.96 | 9.9 | 7.61 | 7.51 | Upgrade
|
Operating Income | 1.27 | 1.2 | -0.14 | 0.29 | 2.2 | 1.69 | Upgrade
|
Interest Expense | -0.03 | -0.03 | -0.03 | -0.02 | -0.06 | -0.21 | Upgrade
|
Other Non Operating Income (Expenses) | -0.14 | -0.14 | -0.13 | -0.13 | -0.13 | -0.14 | Upgrade
|
EBT Excluding Unusual Items | 1.09 | 1.03 | -0.31 | 0.13 | 2.01 | 1.34 | Upgrade
|
Other Unusual Items | - | - | - | - | - | 0.47 | Upgrade
|
Pretax Income | 1.09 | 1.03 | -0.31 | 0.13 | 2.01 | 1.81 | Upgrade
|
Income Tax Expense | 0.41 | 0.41 | 0.03 | 0.16 | -2.01 | -0.31 | Upgrade
|
Net Income | 0.68 | 0.61 | -0.33 | -0.02 | 4.02 | 2.12 | Upgrade
|
Preferred Dividends & Other Adjustments | 0.2 | 0.2 | 0.2 | - | - | - | Upgrade
|
Net Income to Common | 0.48 | 0.42 | -0.53 | -0.02 | 4.02 | 2.12 | Upgrade
|
Net Income Growth | - | - | - | - | 89.91% | - | Upgrade
|
Shares Outstanding (Basic) | 71 | 71 | 71 | 70 | 70 | 70 | Upgrade
|
Shares Outstanding (Diluted) | 78 | 77 | 71 | 70 | 75 | 74 | Upgrade
|
Shares Change (YoY) | 9.69% | 8.51% | 0.28% | -6.01% | 0.88% | 6.10% | Upgrade
|
EPS (Basic) | 0.01 | 0.01 | -0.01 | -0.00 | 0.06 | 0.03 | Upgrade
|
EPS (Diluted) | 0.01 | 0.01 | -0.01 | -0.00 | 0.05 | 0.03 | Upgrade
|
EPS Growth | - | - | - | - | 86.21% | - | Upgrade
|
Free Cash Flow | 1.93 | 1.06 | 1.2 | 0.68 | 3.7 | 2.53 | Upgrade
|
Free Cash Flow Per Share | 0.03 | 0.01 | 0.02 | 0.01 | 0.05 | 0.03 | Upgrade
|
Dividend Per Share | 0.010 | 0.010 | 0.010 | 0.010 | - | - | Upgrade
|
Gross Margin | 79.34% | 79.65% | 78.14% | 79.67% | 82.88% | 86.99% | Upgrade
|
Operating Margin | 7.54% | 7.27% | -1.04% | 2.25% | 18.57% | 15.97% | Upgrade
|
Profit Margin | 2.87% | 2.53% | -3.83% | -0.18% | 33.93% | 20.01% | Upgrade
|
Free Cash Flow Margin | 11.46% | 6.46% | 8.67% | 5.30% | 31.23% | 23.95% | Upgrade
|
EBITDA | 1.44 | 1.41 | 0.07 | 1.53 | 3.31 | 2.41 | Upgrade
|
EBITDA Margin | 8.56% | 8.53% | 0.49% | 11.98% | 27.98% | 22.82% | Upgrade
|
D&A For EBITDA | 0.17 | 0.21 | 0.21 | 1.24 | 1.11 | 0.72 | Upgrade
|
EBIT | 1.27 | 1.2 | -0.14 | 0.29 | 2.2 | 1.69 | Upgrade
|
EBIT Margin | 7.54% | 7.27% | -1.04% | 2.25% | 18.57% | 15.97% | Upgrade
|
Effective Tax Rate | 37.71% | 40.14% | - | 116.66% | - | - | Upgrade
|
Revenue as Reported | 16.82 | 16.48 | 13.85 | 12.78 | 11.84 | 11.04 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.